John Crowley
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Oncology top 0.05%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Hematology 176
- Multiple Myeloma Research and Treatments 173
- Oncology 116
- Cancer Treatment and Pharmacology 46
- Lung Cancer Research Studies 28
- Peptidase Inhibition and Analysis 28
- Co-authors
- Bart Barlogie (127 shared papers)Kari Chansky (17 shared papers)Peter Goldstraw (13 shared papers)Ramón Rami–Porta (11 shared papers)Pieter E. Postmus (4 shared papers)Dorothy J. Giroux (13 shared papers)Elias J. Anaissie (48 shared papers)Valerie W. Rusch (8 shared papers)
- Journals
- Blood (96 papers)Journal of Thoracic Oncology (37 papers)Journal of Clinical Oncology (25 papers)Clinical Cancer Research (14 papers)British Journal of Haematology (14 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
John Crowley
353 papers receiving 41.9k citations
John Crowley's Hit Papers
Peers
Comparison fields: 5 of 187
- Hematology 16.4k
- Oncology 14.2k
- Pulmonary and Respiratory Medicine 13.7k
- Genetics 2.4k
- Molecular Biology 13.0k
Countries citing papers authored by John Crowley
This map shows the geographic impact of John Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Crowley more than expected).
Fields of papers citing papers by John Crowley
This network shows the impact of papers produced by John Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Crowley. The network helps show where John Crowley may publish in the future.
Co-authors
The 25 scholars most cited alongside John Crowley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 361 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer Hit paper breakdown → | 2016 | 3512 |
| 2 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours Hit paper breakdown → | 2007 | 3166 |
| 3 | International uniform response criteria for multiple myeloma Hit paper breakdown → | 2006 | 2288 |
| 4 | Antitumor Activity of Thalidomide in Refractory Multiple Myeloma Hit paper breakdown → | 1999 | 2193 |
| 5 | The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer Hit paper breakdown → | 2007 | 1405 |
| 6 | Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial Hit paper breakdown → | 2017 | 1128 |
| 7 | Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial Hit paper breakdown → | 2001 | 988 |
| 8 | The molecular classification of multiple myeloma Hit paper breakdown → | 2006 | 927 |
| 9 | A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 Hit paper breakdown → | 2006 | 764 |
| 10 | Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study Hit paper breakdown → | 2011 | 652 |
| 11 | Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma Hit paper breakdown → | 2006 | 614 |
| 12 | The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer Hit paper breakdown → | 2015 | 605 |
| 13 | The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer Hit paper breakdown → | 2016 | 594 |
| 14 | 2002 | 545 | |
| 15 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer Hit paper breakdown → | 2007 | 542 |
| 16 | Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study Hit paper breakdown → | 2005 | 529 |
| 17 | The International Association for the Study of Lung Cancer Lung Cancer Staging Project Hit paper breakdown → | 2015 | 529 |
| 18 | 1997 | 462 | |
| 19 | 1999 | 456 | |
| 20 | 2009 | 426 |
About John Crowley
John Crowley is a scholar working on Hematology, Oncology, Statistics and Probability, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 361 papers that have together received 43.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (173 papers), Protein Degradation and Inhibitors (70 papers), Cancer Treatment and Pharmacology (46 papers), Statistical Methods in Clinical Trials (36 papers), Cancer therapeutics and mechanisms (32 papers), Lung Cancer Diagnosis and Treatment (29 papers), Lung Cancer Research Studies (28 papers) and Peptidase Inhibition and Analysis (28 papers). The work is most often cited by research in Hematology (16.4k citations), Oncology (14.2k citations), Pulmonary and Respiratory Medicine (13.7k citations), Genetics (2.4k citations) and Molecular Biology (13.0k citations). John Crowley has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Bart Barlogie, Kari Chansky, Peter Goldstraw, Ramón Rami–Porta, Pieter E. Postmus, Dorothy J. Giroux, Elias J. Anaissie, Valerie W. Rusch, Frits van Rhee and Guido J. K. Tricot. Their work appears in journals such as Blood, Journal of Thoracic Oncology, Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.